Guardant Health, Inc. $GH is Capricorn Fund Managers Ltd's 6th Largest Position

Got story updates? Submit your updates here. ›

Capricorn Fund Managers Ltd increased its holdings in Guardant Health, Inc. (NASDAQ:GH) by 197.8% in the fourth quarter, according to a recent SEC filing. The fund now owns 107,787 shares of the company's stock, making it the 6th largest position in Capricorn's portfolio.

Why it matters

Guardant Health is a leading precision oncology company that develops non-invasive blood tests to detect and profile cancer genomic alterations. This significant increase in ownership by Capricorn Fund Managers suggests the institutional investor sees strong growth potential in the company's cancer diagnostics technology.

The details

According to the 13F filing, Capricorn Fund Managers Ltd acquired an additional 71,587 shares of Guardant Health in the fourth quarter, bringing its total position to 107,787 shares. This represents approximately 0.09% of the company's outstanding shares and makes Guardant Health the 6th largest holding in Capricorn's portfolio, accounting for 2.7% of its total assets.

• Capricorn Fund Managers Ltd increased its Guardant Health stake in the fourth quarter of 2025.
• The 13F filing disclosing the increased position was submitted on April 6, 2026.